JP Morgan Chase’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$223K Sell
53,109
-3,018
-5% -$13.3K ﹤0.01% 5560
2026
Q1
$202K Sell
56,127
-4,697
-8% -$16.3K ﹤0.01% 5466
2025
Q4
$207K Sell
60,824
-117
-0.2% -$568 ﹤0.01% 5525
2025
Q3
$414K Sell
60,941
-351,630
-85% -$2.9M ﹤0.01% 5140
2025
Q2
$5.62M Buy
412,571
+352,004
+581% +$3.32M ﹤0.01% 3043
2025
Q1
$329K Buy
60,567
+5,363
+10% +$30.4K ﹤0.01% 5020
2024
Q4
$273K Sell
55,204
-32,969
-37% -$173K ﹤0.01% 5339
2024
Q3
$462K Buy
88,173
+73,389
+496% +$423K ﹤0.01% 4949
2024
Q2
$101K Buy
+14,784
New +$135K ﹤0.01% 5509
2023
Q2
Sell
-88,792
Closed -$151K 7154
2023
Q1
$151K Buy
+88,792
New +$157K ﹤0.01% 5226

Other funds holding LFMD

JP Morgan Chase's LFMD Position: Q2 2026 in Review

JP Morgan Chase reduced its LifeMD (LFMD) stake by 5.4% in Q2 2026, selling an estimated $13.3K and leaving 53,109 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #5560.

JP Morgan Chase first reported a position in LFMD in Q1 2023 and has held it in 10 quarters since. The position peaked at $5.62M in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • JP Morgan Chase held 53,109 shares of LifeMD worth $223K as of Q2 2026.
  • JP Morgan Chase sold 3,018 LifeMD shares in Q2 2026, an estimated $13.3K.
  • LifeMD made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5560 holding.
  • JP Morgan Chase first reported a position in LifeMD in Q1 2023 and has held it in 10 quarters since.
  • JP Morgan Chase's LifeMD position peaked at $5.62M in Q2 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.